Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06264726 · ClinicalTrials.gov registry record · NA
CommunityRx-Cardiovascular Disease
A NA study of Cardiovascular Diseases and Self Efficacy, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 325
- Enrollment target
- 2
- Study locations
NCT06264726 is a NA study of Cardiovascular Diseases and Self Efficacy that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 325 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06264726, a NA study of Cardiovascular Diseases and Self Efficacy, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this single arm pre-test post-test design study is to test the impact of providing patients with information about community-based resources to address health-related social needs and cardiometabolic health in rural African American patients. The main question it aims to answer is: • What is the effectiveness of community resource information on patient self-efficacy to use community resources? Participants will be given: * A personalized "HealtheRx" resource with information about community resources related to food, housing, utility support, transportation, and crisis support. The HealtheRx is personalized for patients based on their age and zip code. * Access to a community resource navigator for support with using the HealtheRx upon request * 2 text messages with reminders about the HealtheRx and access to the community resource navigator
Conditions Studied
Interventions
- OTHER HealtheRx
Study Locations (2)
North Carolina
- OIC Family Medical Center - Fairview - Rocky Mount
- OIC Family Medical Center - Happy Hill - Rocky Mount
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06264726
The ClinicalTrials.gov registry entry for NCT06264726 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which HealtheRx is the first listed.
NCT06264726 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06264726 about?
NCT06264726 is a clinical study titled "CommunityRx-Cardiovascular Disease". The goal of this single arm pre-test post-test design study is to test the impact of providing patients with information about community-based resources to address health-related social needs and cardiometabolic health in rural African American patients. The main question it aims to answer is: • Wh...
What is the current status of trial NCT06264726?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2024-03-12. Estimated completion is 2025-10-30.
What conditions does trial NCT06264726 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Self Efficacy.
What interventions are being tested in trial NCT06264726?
The interventions under investigation include: HealtheRx (OTHER).
Who is sponsoring clinical trial NCT06264726?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06264726 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.